Give additional information on Covaxin: WHO tells Bharat Biotech Ruchika Sharma27 Oct 2021 11:41 AM ISTThe Covaxin has demonstrated 77.8 percent effectiveness against symptomatic COVID-19 and 65.2 percent protection against the new Delta variant.
Pfizer COVID vaccine gets USFDA panel nod for kids aged 5-11 MD Bureau27 Oct 2021 10:00 AM ISTWashington: The US Food and Drug Administration's advisory committee has endorsed Pfizer's Covid-19 vaccine for children aged 5 to 11. The...
Covaxin, Covishield cocktail safe, says ICMR study Roshni Dhar26 Oct 2021 3:58 PM ISTA combination of Covishield and Covaxin shots is safe and, in fact, offers better immunogenicity than two doses of the same vaccine, says a limited...
India crossed 1 billion vaccination milestone Roshni Dhar26 Oct 2021 3:57 PM ISTThe country now has a strong "protective shield" of 100 crore vaccine doses to combat the biggest pandemic in 100 years, Prime Minister Narendra Modi...
Health Bulletin 25/October/2021 Roshni Dhar25 Oct 2021 4:23 PM ISTHere are Top Health Stories of the dayDoctors cannot function under threat of being harassed, beaten up: High CourtThe Punjab and Haryana High Court...
Biological E anticipates Covid-19 vaccine Corbevax rollout by November MD Bureau25 Oct 2021 4:02 PM ISTHyderabad: Hyderabad-based vaccine maker, Biological E expects the rollout of its Covid-19 vaccine 'Corbevax' by the end of November and is looking to...
Waiting for DCGI nod for children's Covid-19 vaccine: Bharat Biotech Chief Ruchika Sharma25 Oct 2021 1:03 PM ISTNew Delhi: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs...
Molnupiravir may be game changer in fight against Covid-19: Expert MD Bureau24 Oct 2021 9:00 AM ISTHyderabad: Anti-viral drug Molnupiravir may emerge as the game changer in the fight against Covid-19 as studies suggest it can reduce the risk of...
As Covaxin decision awaited, WHO says EUL recommendation process sometimes takes longer Ruchika Sharma23 Oct 2021 4:01 PM ISTNew Delhi: As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of...
Pfizer COVID vaccine benefits outweigh key risks in children 5 to 11, says USFDA Ruchika Sharma23 Oct 2021 4:00 PM ISTNew Delhi: Scientists at the U.S. Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer /BioNTech COVID-19...
With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more entrenched Ruchika Sharma22 Oct 2021 3:03 PM ISTNew Delhi: As the country achieved the milestone of vaccinating over 100 crore Indians against COVID-19 on Thursday, India's role as the pharmacy of...
COVID booster shot showed high efficacy in large study: Pfizer, BioNTech Ruchika Sharma22 Oct 2021 3:01 PM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and...
